This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abraham, B. K. Search for Related Content PubMed PubMed Citation Articles by Abraham, B. K.

Investigation of Genetic Variants of Genes of the Hemochromatosis Pathway and Their Role in Breast Cancer

¹ Division of Mechanisms of Origin and Treatment of Breast Cancer, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; ² Berufsgenossenschaftliches Forschungsinstitut für Arbeitsmedizin, Ruhr-Universität Bochum, Bochum, Germany; ³ Institute für Allgemeine Pathologie und Pathologische Anatomie, Technische Universität München, Munich, Germany; ⁴ Deutsches Krebsforschungszentrum Heidelberg, Heidelberg, Germany; ⁵ Medizinische Universitäts und Poliklinik, Universität Bonn and Abteilung für Innere Medizin, Johanniter-Krankenhaus Bonn; ⁶ Institut of Pathology, Universität Bonn, Bonn, Germany; and ⁷ ViennaLab Labordiagnostika GmbH, Vienna, Austria

Requests for reprints: Hiltrud Brauch, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Auerbachstrasse 112, D-70376 Stuttgart, Germany. Phone: 49-711-8101-3705; Fax: 49-711-859-295. E-mail: hiltrud.brauch{at}ikp-stuttgart.de

Iron overload has been noticed as a feature of human breast cancer. Cellular iron uptake is regulated by the hemochromatosis and transferrin receptor system, mutations of which cause the iron storage disease hereditary hemochromatosis. To understand the role of hemochromatosis and transferrin receptor system mutations in breast cancer, we analyzed 19 sequence variations at HFE, TFR1, TFR2, and FPN1 and compared genotype frequencies between cases and controls in a German population. There were 688 breast cancer patients and 724 population-based and age-matched controls. For genotyping, we applied the Hemochromatosis Strip Assay and TaqMan allelic discrimination analyses. In addition to genotype frequencies, we established frequencies of compound genotypes. The frequencies of HFE at His63Asp, Ser65Cys, and Cys282Tyr, and of TFR1 at Ser142Gly minor alleles in this German population were 15.9%, 1.8%, 5.6%, and 46.0%, respectively. No rare variants at 15 more loci at HFE, TFR2, and FPN1 were observed in breast cancer patients. There were no significant differences of allele and genotype frequencies between cases and controls. Triple and quadruple compound genotypes at HFE_His63_Cys282-TFR1_Ser142Gly and HFE_His63_Ser65_Cys282-TFR1_Ser142Gly showed a nonsignificant increase in cases. Although limited by low numbers, an increased prevalence of the HFE Tyr282 minor allele was observed in breast cancer cases with a high number of affected lymph nodes (P = 0.032). Our data suggest that variants of the hemochromatosis-transferrin receptor system have no direct effect on the incidence of breast cancer in Germany. Possible effects on tumor progression and prognosis remain elusive.

This article has been cited by other articles:

				Y. Cui, S. Vogt, N. Olson, A. G. Glass, and T. E. Rohan Levels of Zinc, Selenium, Calcium, and Iron in Benign Breast Tissue and Risk of Subsequent Breast Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1682 - 1685. [Abstract] [Full Text] [PDF]